-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) -Prior authorization of molecular tests
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2026
- Income
- Not reported
- Expenses
- $140,000.00
- Registrant
- CAREDX, INC.
- Client
- CAREDX, INC.
- Filing UUID
- 1a0fcb01-273d-4f4f-9a91-0589b78d8fb2
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Living Donor Protection Act (LDPA) S1522, HR4582,HR4583
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.